Future-health keynote · Pillar 6
AI and the Private Future of Healthcare
Future-health keynote · particularly strong as a co-keynote with Dr. Barbara Bauder
Health data is among the most valuable data there is, and also among the least protected.
AI will make prevention dramatically better and privacy dramatically harder. Both statements can be true at the same time, yet most keynotes focus on only one side of the argument.
This one does not.
The talk in one paragraph
Most AI-in-health keynotes are delivered either as a warning or as a sales pitch, and very few are given by someone who actually uses these systems in clinical practice.
Dr. Robert Bauder speaks as an early adopter and practising clinician: where AI genuinely improves pattern recognition and prevention today, where it produces confident but incorrect answers, and what health sovereignty means when the data in question comes from a person’s own body. The talk closes with the three questions to ask before handing health data to any system. A practical takeaway rather than a prediction.
The clinician’s angle
Most speakers on this topic have never had to explain a diagnosis to a frightened patient, and that perspective is often missing from the conversation.
Dr. Bauder’s material comes from practical use, not forecasting. Where does pattern recognition genuinely identify things a human might miss? Where does it produce an answer that sounds fluent, plausible and convincing, but is wrong? And how would a patient know the difference? What changes in the consultation itself when both doctor and patient have already asked an AI model?
These are the questions a health audience actually has, and they require a clinical perspective rather than a purely theoretical one.
Health sovereignty
The current debate often treats sovereign AI as an infrastructure question for governments and corporations. For individuals, the question is more personal: who holds your health data? What can be inferred from it? And what can become known about you even though you never chose to disclose it?
This is why the talk works on privacy and policy stages as well as at health events. It is not a lecture on regulation. It is a decision framework for individuals and for the organisations that hold their data.
As a co-keynote
Together with Dr. Barbara Bauder, this becomes a two-perspective session: the clinical view and the entrepreneurial, data-sovereignty perspective. They work from the same framework but do not always reach the same conclusion, which creates a genuine exchange on stage rather than two separate presentations.
The duo format is available in person only. The interaction between both speakers is a central part of the keynote and works significantly better live than through a video grid. The duo keynote
What happens on stage
Five acts. One mechanism.
The structure is planned; the delivery is not scripted.
01
What already works
Concrete clinical examples where AI improves detection and prevention today, with the limitations explained at the same time.
02
Where it fails convincingly
One of the most dangerous failure modes: answers that are fluent, confident and wrong, and why that matters especially in healthcare.
03
Who owns the inference
Not only the data question everyone asks, but the harder one: what can be derived about you from information you never explicitly provided.
04
The three questions
A short, practical test to apply before any tool touches health data.
05
The premium expectation
Why private and secure options may move from a niche offering to something patients and employees actively expect.
Take-aways
What your audience leaves with.
What AI already does well in prevention today, explained concretely enough to act on.
The three questions to ask before handing over health data, for individuals and organisations.
Why private options may become a premium expectation rather than a niche, and what that means for anyone building health services.
How to distinguish a genuine clinical AI application from an impressive demonstration with little practical value.
Who books this talk
Future-health and digital-health eventsTech and AI conferences looking for a domain expert rather than another generalistPolicy and privacy panelsCorporate innovation programmesMedical congresses with a digital-health track
Why Dr. Robert Bauder
A practising clinician, not only a science communicator.
Early adopter: uses AI systems in his own clinical practice.
30 years of clinical practice and more than 11,000 patients — the consultation-room perspective.
Founder of Bio-Longevity Dentistry® and the Silent Root Cause® method.
Peer-reviewed, PubMed-indexed multicentre study.
Co-keynote partner of Dr. Barbara Bauder, author of two books on private and sovereign AI.
Frequently asked questions
Is this a technical talk?
No. It requires no technical background and contains no architecture diagrams.
Is it optimistic or critical?
Both, deliberately. Dr. Robert Bauder focuses on what already works, while being equally clear about the limitations and risks.
Does it cover regulation?
It covers the practical consequences rather than detailed legal interpretation. Dr. Barbara Bauder addresses the sovereignty and regulatory perspective in greater depth.
Is it available virtually?
Yes. The solo keynote works well remotely. The duo version is available in person only.
Booking
Request this keynote — reply within 24 hours.
You receive availability and a topic recommendation within 24 hours. English or German. In person across Europe, virtual worldwide.